Daily spirometry in an acute exacerbation of adult cystic fibrosis patients

被引：3

作者：

Stephen, Michael J. ^{[1
]}

Long, Alex ^{[2
]}

Bonsall, Chad ^{[3
]}

Hoag, Jeffrey B. ^{[1
]}

Shah, Smita ^{[4
]}

Bisberg, Dorothy ^{[4
]}

Holsclaw, Douglas ^{[3
]}

Varlotta, Laurie ^{[5
]}

Fiel, Stan ^{[6
]}

Du, Doantrang ^{[7
]}

Zanni, Robert ^{[7
]}

Hadjiliadis, Denis ^{[3
]}

机构：

[1] Drexel Univ, Sch Med, Div Pulm & Crit Care, Philadelphia, PA USA

[2] Drexel Univ, Sch Publ Hlth, Philadelphia, PA USA

[3] Univ Penn, Div Pulm & Crit Care, Philadelphia, PA USA

[4] Pediat Specialty Ctr, St Barnabas Med Ctr, Barnabas Hlth Med Grp, W Orange, NJ USA

[5] St Christophers Hosp Children, Philadelphia, PA USA

[6] Atlantic Hlth Syst, Morristown, NJ USA

[7] Monmouth Med Ctr, Long Branch, NJ USA

来源：

CHRONIC RESPIRATORY DISEASE | 2018年 / 15卷 / 03期

关键词：

Cystic fibrosis; acute exacerbation; home spirometry; CFQ-R; intravenous antibiotics; QUALITY-OF-LIFE; PULMONARY EXACERBATIONS; RESPIRATORY EXACERBATIONS; ANTIBIOTIC-TREATMENT; MORTALITY; OUTCOMES;

D O I：

10.1177/1479972317743756

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

To help answer the question of length of intravenous antibiotics during an acute exacerbation of cystic fibrosis (CF), we had subjects to follow daily home spirometry while on intravenous antibiotics. CF patients, 18 and older, with an acute exacerbation requiring intravenous antibiotics had a daily FEV1. The average time to a 10% increase over their initial sick FEV1 was calculated, as well as the time to a new baseline. A total of 25 subjects completed the study. Ten of the 25 subjects did not have a sustainable 10% increase in FEV1. Of the 15 subjects with a sustainable 10% increase in FEV1, it took 5.2 days (+/- 4.5) after day 1, while a new baseline was achieved on average at 6.6 days (+/- 4.8) after day 1. Given the wide range of time to a 10% improvement and new baseline, it is recommended there should be flexibility in length of intravenous antibiotics in CF, not by a preset number.

引用

页码：258 / 264

页数：7

共 50 条

[1] Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
de Boer, Kaissa
Vandemheen, Katherine L.
Tullis, Elizabeth
Doucette, Steve
Fergusson, Dean
Freitag, Andreas
Paterson, Nigel
Jackson, Mary
Lougheed, M. Diane
Kumar, Vijay
Aaron, Shawn D.
THORAX, 2011, 66 (08) : 680 - 685
[2] Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation
Kidd, James M.
Sakon, Colleen M.
Oleksiuk, Louise-Marie
Cies, Jeffrey J.
Pettit, Rebecca S.
Nicolau, David P.
Kuti, Joseph L.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
[3] Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis
Carter, Suzanne C.
Franciosi, Alessandro N.
O'Shea, Kate M.
O'Carroll, Orla M.
Sharma, Ashutosh
Bell, Aoife
Keogan, Brian
O'Reilly, Paul
Coughlan, Suzie
Law, Sheonagh M.
Gray, Robert D.
Hisert, Katherine B.
Singh, Pradeep K.
Cooke, Gordon
Grogan, Brenda
De Gascun, Cillian F.
Gallagher, Charles G.
Nicholson, Trevor T.
Quon, Bradley S.
McKone, Edward F.
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (11) : 1818 - 1826
[4] Early detection of infectious exacerbations by daily home spirometry in patients with cystic fibrosis
Izbicki, G
Trachsel, D
Rutishauser, M
Perruchoud, AP
Tamm, M
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 130 (39) : 1361 - 1365
[5] Daily physical activity in adult patients with cystic fibrosis
Prevotat, A.
Denis, F.
Leroy, S.
Garet, M.
Wemeau-Stervinou, L.
Perez, T.
Halm, A. -M.
Wallaert, B.
REVUE DE PNEUMOLOGIE CLINIQUE, 2013, 69 (01) : 3 - 9
[6] Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Morlacchi, Letizia Corinna
Rosti, Valentina
Elia, Rita
Mantero, Marco
Dallari, Barbara
Galbiati, Samantha
Zanardelli, Maddalena
D'Adda, Alice
Blasi, Francesco
Pizzamiglio, Giovanna
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[7] Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis
Sequeiros, Iara Maria
Jarad, Nabil
CHRONIC RESPIRATORY DISEASE, 2012, 9 (01) : 9 - 16
[8] Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV1 decline
Barboza de Aquino, Carolina Silva
Rodrigues, Joaquim Carlos
Ferreira da Silva-Filho, Luiz Vicente Ribeiro
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2022, 48 (03)
[9] Spirometry in early childhood in cystic fibrosis patients
Vilozni, Daphna
Bentur, Lea
Efrati, Oti
Minuskin, Tal
Barak, Asher
Szeinberg, Amir
Blau, Hannah
Picard, Elie
Kerem, Eitan
Yahav, Yaacov
Augarten, Arie
CHEST, 2007, 131 (02) : 356 - 361
[10] The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
Carmody, Lisa A.
Zhao, Jiangchao
Kalikin, Linda M.
LeBar, William
Simon, Richard H.
Venkataraman, Arvind
Schmidt, Thomas M.
Abdo, Zaid
Schloss, Patrick D.
LiPuma, John J.
MICROBIOME, 2015, 3

← 1 2 3 4 5 →